{"id":"https://openalex.org/W2005367228","doi":"https://doi.org/10.1097/mjt.0000000000000027","title":"Cardiovascular Safety Monitoring During Oncology Drug Development and Therapy","display_name":"Cardiovascular Safety Monitoring During Oncology Drug Development and Therapy","alternate_titles":[],"publication_year":2014,"publication_date":"2014-01-22","ids":{"openalex":"https://openalex.org/W2005367228","doi":"https://doi.org/10.1097/mjt.0000000000000027","mag":"2005367228","pmid":"https://pubmed.ncbi.nlm.nih.gov/24451296"},"language":"en","primary_location":{"id":"doi:10.1097/mjt.0000000000000027","doi":"https://doi.org/10.1097/mjt.0000000000000027","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mjt.0000000000000027","pdf_url":null,"source":{"id":"https://openalex.org/S67118044","display_name":"American Journal of Therapeutics","issn_l":"1075-2765","issn":["1075-2765","1536-3686"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005367228"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112767709","display_name":"J. Rick Turner","orcid":"https://orcid.org/0000-0001-5971-2289","observed_orcids":["https://orcid.org/0000-0001-5971-2289"]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Rick Turner","raw_affiliation_strings":["1Quintiles Cardiac Safety Center of Excellence, Durham, NC; 2Quintiles Cardiac Safety Services, Mumbai, India; 3Quintiles Therapeutic Delivery Unit, Durham, NC; and 4Quintiles Oncology Therapeutic Area, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Quintiles Cardiac Safety Center of Excellence, Durham, NC; 2Quintiles Cardiac Safety Services, Mumbai, India; 3Quintiles Therapeutic Delivery Unit, Durham, NC; and 4Quintiles Oncology Therapeutic Area, Rockville, MD","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072410250","display_name":"Gopi Krishna Panicker","orcid":"https://orcid.org/0000-0002-7776-3458","observed_orcids":["https://orcid.org/0000-0002-7776-3458"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gopi Krishna Panicker","raw_affiliation_strings":["2Quintiles Cardiac Safety Services, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Quintiles Cardiac Safety Services, Mumbai, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066955105","display_name":"Dilip R. Karnad","orcid":"https://orcid.org/0000-0001-9935-5028","observed_orcids":["https://orcid.org/0000-0001-9935-5028"]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dilip R. Karnad","raw_affiliation_strings":["3Quintiles Therapeutic Delivery Unit, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Quintiles Therapeutic Delivery Unit, Durham, NC","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062709502","display_name":"Christopher H. Cabell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher H. Cabell","raw_affiliation_strings":["and 4Quintiles Oncology Therapeutic Area, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"and 4Quintiles Oncology Therapeutic Area, Rockville, MD","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111967681","display_name":"Ronald Lieberman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronald Lieberman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5018298621","display_name":"Snehal Kothari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Snehal Kothari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4217,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.42417123,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"21","issue":"6","first_page":"512","last_page":"522"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11638","display_name":"Cardiac tumors and thrombi","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cardiovascular-safety","display_name":"cardiovascular safety","score":0.6489999890327454},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.8040000200271606},{"id":"https://openalex.org/keywords/oncology-drugs","display_name":"oncology drugs","score":0.796999990940094},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.5540000200271606},{"id":"https://openalex.org/keywords/risk-benefit-assessment","display_name":"risk-benefit assessment","score":0.8429999947547913},{"id":"https://openalex.org/keywords/ich-e14","display_name":"ICH E14","score":0.8980000019073486},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.6710000038146973},{"id":"https://openalex.org/keywords/cardiac-arrhythmia","display_name":"cardiac arrhythmias","score":0.8999999761581421},{"id":"https://openalex.org/keywords/thromboembolic-events","display_name":"thromboembolic events","score":0.9409999847412109},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.8180000185966492},{"id":"https://openalex.org/keywords/cardiac-function-monitoring","display_name":"cardiac function monitoring","score":0.7419999837875366},{"id":"https://openalex.org/keywords/anthracycline-analogs","display_name":"anthracycline analogues","score":0.9039999842643738},{"id":"https://openalex.org/keywords/myocardial-injury-markers","display_name":"myocardial injury biomarkers","score":0.8790000081062317},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9742491245269775},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.534906268119812},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.49692443013191223},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.47610270977020264},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41439956426620483},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3756187856197357},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3342167139053345}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D066126","descriptor_name":"Cardiotoxicity","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D066126","descriptor_name":"Cardiotoxicity","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D066126","descriptor_name":"Cardiotoxicity","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/mjt.0000000000000027","doi":"https://doi.org/10.1097/mjt.0000000000000027","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mjt.0000000000000027","pdf_url":null,"source":{"id":"https://openalex.org/S67118044","display_name":"American Journal of Therapeutics","issn_l":"1075-2765","issn":["1075-2765","1536-3686"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Therapeutics","raw_type":"journal-article"},{"id":"pmid:24451296","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24451296","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W1232760234","https://openalex.org/W1505612411","https://openalex.org/W1586974265","https://openalex.org/W1604542334","https://openalex.org/W1965024282","https://openalex.org/W1970948342","https://openalex.org/W1975438579","https://openalex.org/W1981322379","https://openalex.org/W1985856395","https://openalex.org/W1997218466","https://openalex.org/W2001122447","https://openalex.org/W2004291012","https://openalex.org/W2012361366","https://openalex.org/W2023606650","https://openalex.org/W2030673823","https://openalex.org/W2034343992","https://openalex.org/W2035437970","https://openalex.org/W2043069435","https://openalex.org/W2043704268","https://openalex.org/W2044365534","https://openalex.org/W2047744443","https://openalex.org/W2050036109","https://openalex.org/W2077135808","https://openalex.org/W2079502932","https://openalex.org/W2081308821","https://openalex.org/W2084304742","https://openalex.org/W2091286041","https://openalex.org/W2091557317","https://openalex.org/W2106130415","https://openalex.org/W2109346300","https://openalex.org/W2113927644","https://openalex.org/W2118466253","https://openalex.org/W2119375148","https://openalex.org/W2126970264","https://openalex.org/W2128143798","https://openalex.org/W2130666159","https://openalex.org/W2135400595","https://openalex.org/W2137598126","https://openalex.org/W2142196046","https://openalex.org/W2149159105","https://openalex.org/W2150707594","https://openalex.org/W2157769714","https://openalex.org/W2162731664","https://openalex.org/W2167227347","https://openalex.org/W2310423757","https://openalex.org/W4211178425","https://openalex.org/W4235435263"],"related_works":["https://openalex.org/W2480657710","https://openalex.org/W4391150371","https://openalex.org/W1710266050","https://openalex.org/W2128498298","https://openalex.org/W2063621325","https://openalex.org/W2060248464","https://openalex.org/W2909015916","https://openalex.org/W867233511","https://openalex.org/W2018865905","https://openalex.org/W2027346433"],"abstract_inverted_index":{"Assessments":[0],"of":[1,9,46,77,134,182,188,194,197,207,222,226,234],"cardiac":[2,164,218],"and":[3,16,104,126,168,172,190,200,205,229,231],"cardiovascular":[4,156,195],"toxicity":[5],"are":[6,102],"prominent":[7],"components":[8],"drug":[10,14,29],"safety":[11,196],"endeavors":[12],"during":[13,28],"development":[15],"clinical":[17,95,192],"practice.":[18],"Oncologic":[19,148],"drugs":[20,69,88,149,210],"bring":[21],"several":[22],"challenges":[23],"to":[24,34,53,144,161],"both":[25],"domains.":[26],"First,":[27],"development,":[30],"it":[31],"is":[32,97],"necessary":[33],"adapt":[35],"the":[36,43,66,180],"ICH":[37],"E14":[38],"\"Thorough":[39],"QT/QTc":[40],"Study\"":[41],"because":[42],"cytotoxic":[44],"nature":[45],"many":[47,118,130],"oncologics":[48],"precludes":[49],"their":[50],"being":[51],"administered":[52],"healthy":[54],"individuals.":[55],"Second,":[56],"appropriate":[57],"benefit-risk":[58,183],"assessments":[59],"must":[60],"be":[61,80],"made":[62],"by":[63],"regulators:":[64],"given":[65],"benefit":[67],"these":[68],"provide":[70],"in":[71,117],"life-threatening":[72],"illnesses,":[73],"a":[74,145],"greater":[75],"degree":[76],"risk":[78],"may":[79],"acceptable":[81],"when":[82],"granting":[83],"marketing":[84],"authorization":[85],"than":[86],"for":[87,89,99,129,203],"less":[90],"severe":[91],"indications.":[92],"Third,":[93],"considerable":[94],"consideration":[96],"needed":[98],"patients":[100,127,208],"who":[101],"receiving":[103,107,209],"have":[105,150],"finished":[106],"pharmacotherapy.":[108],"Paradoxically,":[109],"although":[110],"such":[111],"therapy":[112],"has":[113],"proved":[114],"very":[115],"successful":[116],"cases,":[119],"with":[120,153,211],"disease":[121],"states":[122],"going":[123],"into":[124],"remission":[125],"living":[128],"years":[131],"after":[132],"cessation":[133],"treatment,":[135],"cardiotoxicities":[136],"can":[137],"manifest":[138],"themselves":[139],"relatively":[140],"soon":[141],"or":[142],"up":[143],"decade":[146],"later.":[147],"been":[151],"associated":[152],"various":[154],"off-target":[155],"responses,":[157],"including":[158],"cardiomyopathy":[159],"leading":[160],"heart":[162],"failure,":[163],"dysrhythmias,":[165],"thromboembolic":[166],"events,":[167],"hypertension.":[169],"Follow-up":[170],"attention":[171],"care":[173],"are,":[174],"therefore,":[175],"critical.":[176],"This":[177],"article":[178],"reviews":[179],"process":[181],"estimation,":[184],"provides":[185],"an":[186],"overview":[187],"nonclinical":[189],"preapproval":[191],"assessment":[193],"oncology":[198],"drugs,":[199],"discusses":[201],"strategies":[202],"monitoring":[204],"management":[206],"known":[212],"cardiotoxicity":[213],"risk.":[214],"These":[215],"measures":[216],"include":[217],"function":[219],"monitoring,":[220],"limitation":[221],"chemotherapy":[223],"dose,":[224],"use":[225],"anthracycline":[227],"analogs":[228],"cardioprotectants,":[230],"early":[232],"detection":[233],"myocardial":[235],"cell":[236],"injury":[237],"using":[238],"biomarkers.":[239]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005367228","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
